GlaxoSmithKline sets sights on carbon neutrality

Drug company GlaxoSmithKilne has committed to becoming carbon neutral by 2050. It has already cut emissions by 4% over the past three years, but questions remain over how it will achieve its goal.

Ribena production line. Credit: GSK
Ribena production line. Credit: GSK

Sign in to continue

Sign in

Trouble signing in?

Reset password: Click here

Email: report@ends.co.uk

Call: 020 8267 8120

Register for
Free Trial

  • 14 day access to subscriber-only content

Register

Subscribe

Prices on request

  • Full access to endsreport.com for 12 months
  • Monthly print issues
  • Clear and accessible guidance on relevant legislation
  • Integration with ENDS Compliance Manager helping you plan ahead and ensure compliance for your organisation
  • Individual or bespoke multi-user packages available

See all benefits